Head-to-head · computed 2026-08-11
Elevate Health vs TMates
Elevate Health: Elevate Health sells compounded tirzepatide at $449 a month on its monthly plan or $263 a month on a prepaid 12-week program, with free blood work included and brand-name Zepbound also on the menu; its compounded semaglutide pricing spans a promotional band our desk has not resolved to a rankable maintenance figure. TMates: TMates is a compounded GLP-1 telehealth service that includes medication and visits in one bundled monthly price. It offers both semaglutide and tirzepatide, with a 12-month plan that brings tirzepatide to $167/mo — the lowest committed-plan figure for tirz outside of bmiMD and NexLife.
Tirzepatide
| Elevate Health | TMates | |
|---|---|---|
| All-in maintenance | $449/mo | $297/mo |
| Best plan rate | $263/mo | $167/mo |
| 12-month total | $5,388 | $2,004 |
| Status | Reported · 2026-08-11 | Reported · 2026-07-14 |
The arithmetic
On the figures our desk holds, TMates's $297 a month undercuts Elevate Health's $449 by $152 a month at the 10 mg/wk maintenance basis — $1,824 across a year. TMates's figure is reported (captured 2026-07-14) and Elevate Health's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Elevate Health's tirzepatide ladder runs $449 a month billed monthly, and $263 a month on a three-month plan. TMates's runs $297 a month billed monthly, and $167 a month on a twelve-month plan. On the twelve-month basis TMates's $2,004 beats Elevate Health's $5,388 by $3,384 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Semaglutide
| Elevate Health | TMates | |
|---|---|---|
| All-in maintenance | not published | $249/mo |
| Best plan rate | — | $158/mo |
| 12-month total | — | $1,896 |
| Status | Reported · 2026-08-11 | Reported · 2026-07-14 |
The arithmetic
Elevate Health does not publish a rankable maintenance-dose figure for semaglutide, so no winner can honestly be declared — a start-only price tells you what month one costs, not what the program costs.
Where the structures genuinely differ
On verifiability, TMates names its dispensing pharmacy — which means the fifteen-minute license-and-records check is possible — while Elevate Health's pharmacy is not disclosed on record, the single structural fact this desk weighs heaviest after the FDA's 2026 letters cited exactly that practice. On exit terms, TMates's structure avoids prepaid lock-in while Elevate Health's better rates ride prepaid terms — cheaper per month, costlier to leave early; read the refund language before choosing the discount.
Structure, side by side
Elevate Health
- MembershipNone
- Dose policyNot stated on captured materials
- CommitmentMonthly, or 12-week prepaid program
- CancellationPer published terms; 12-week program is prepaid — confirm refund terms at checkout
- PharmacyPartner pharmacy (unnamed on captured materials); clinical network via MDIntegra
TMates
- MembershipNone
- Dose policyStructured titration; medication and provider visits included in price
- Commitment12-month plan or month-to-month; substantial difference in rates
- CancellationPer provider terms
- PharmacyPartner 503A pharmacy (not publicly named)
What our desk is watching on each
Elevate Health: Captures are dated (tirzepatide plan structure from a September 2025 consumer walkthrough; injectable band $233–$263 from January 2026 materials) — re-capture flagged. Three structural notes: checkout precedes medical qualification in the published flow (BMI ≥30, or ≥27 with a condition, gates approval after payment); the dispensing pharmacy is unnamed on captured materials, which fails this desk's verification workflow until answered; and the platform sells peptide add-ons (NAD+, glutathione) alongside GLP-1s — read the verification masterclass's add-on cautions before bundling. Not on the FDA's September 2025 warning-letter list per directory review; Trustpilot rating carries a review-solicitation flag.
TMates: The $158/mo (sema) and $167/mo (tirz) headline figures are 12-month plan rates; month-to-month is $249 (sema) and $297 (tirz) — some of the widest start-to-commitment spreads in the index. Reported status from RangeYourself 2026-07-14 verification.
Questions people ask
Is Elevate Health or TMates cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Elevate Health vs TMates miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Elevate Health and TMates cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $5,388 at Elevate Health and $2,004 at TMates — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Elevate Health · TMates. Official sites: Elevate Health ↗ · TMates ↗. Nothing here is medical advice.